TABLE 2.
MiRNA | Dysregulation | Target | In vitro model | In vivo model | Effects | Reference |
---|---|---|---|---|---|---|
miR-499 | Down | CnAα, CnAβ | Podocytes | MCD mice | Protects podocytes from cytoskeletal damage | Zhang et al. (2018) |
miR-27b | Down | Adora2b | Podocytes | — | Enhances PAN-induced podocytes death | Zheng et al. (2018) |
miR-150 | Down | — | — | MCD patients | As a potential typing indictor | Lu et al. (2015) |
miR-192 | Up | — | — | MCD patients | As a diagnostic and prognostic maker | Cai et al. (2013) |
miR-30b/c, miR-34b/c | Up | — | — | MCD patients | As a diagnostic maker | Ramezani et al. (2015) |
miR-1225-5p | Up | — | — | MCD patients | As a diagnostic maker | Ramezani et al. (2015) |